We found that FASN and FZD10 were prognostic predictors of NPC cancer outcomes, and that inhibiting FASN may enhance NPC cell responsiveness to radiation, probably via downregulating the expression of FZD10. The gene discussed is FASN; the disease is nasopharyngeal carcinoma.